Yoko Narasaki

Dr. Yoko Narasaki

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
YNYoko Narasaki
Yoko Narasaki
Kamyar Kalantar-ZadehKamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh
CRConnie Rhee
Connie Rhee
GBGiuliano Brunori
Giuliano Brunori
DZDiana Zarantonello
Diana Zarantonello
There is rising interest globally with respect to the health implications of vegetarian or plant-based diets. A growing body of evidence has demonstrated that higher consumption of plant-based foods and the nutrients found in vegetarian and plant-based diets are associated with numerous health benefits, including improved blood pressure, glycemic control, lipid levels, body mass index, and acid–base parameters. Furthermore, there has been increasing recognition that vegetarian and plant-based diets may have potential salutary benefits in preventing the development and progression of chronic kidney disease (CKD). While increasing evidence shows that vegetarian and plant-based diets have nephroprotective effects, there remains some degree of uncertainty about their nutritional adequacy and safety in CKD (with respect to protein-energy wasting, hyperkalemia, etc.). In this review, we focus on the potential roles of and existing data on the efficacy/effectiveness and safety of various vegetarian and plant-based diets in CKD, as well as their practical application in CKD management.

2 November 2023 in Journal of Renal Nutrition
Verified
Journal Article
Closed access
DKDuk-Hee Kang
Duk-Hee Kang
ESElani Streja
Elani Streja
AYAmy S. You
Amy S. You
YLYong-kyu Lee
Yong-kyu Lee
YNYoko Narasaki
Yoko Narasaki
CRConnie Rhee
Connie Rhee

18 November 2024 in Current Opinion in Nephrology and Hypertension
Verified
Journal Article
Closed access
YNYoko Narasaki
Yoko Narasaki
CRConnie M. Rhee
Connie M. Rhee
KKKamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh
MRMandana Rastegar
Mandana Rastegar
Purpose of review: Protein-energy wasting (PEW) is increasingly more prevalent as chronic kidney disease (CKD) progresses to more advanced stages. There is a global recognition of the importance of preventing and mitigating PEW in the CKD population not on dialysis given the goal of extending dialysis-free time and delaying dialysis initiation and growing evidence of the clinical consequences of PEW which include the risk of death, hospitalization and clinical conditions such as infections. We reviewed the association of PEW and the malnutrition characteristics indicative of PEW on CKD progression. Recent findings: Studies show the association between low serum albumin levels, low BMI, and diets with inadequate dietary energy and protein intake and CKD progression. Limited studies suggest low muscle mass impacts CKD progression. Optimizing nutrition by dietary management, including a moderately low protein (0.6–0.8 g/kg/day) and plant-based (>50% of protein source, known as PLADO) diet and as needed with supplementation [e.g. during acute kidney injury (AKI) event] administrated orally, enterally, or parenterally are the basis for the prevention and treatment of PEW in CKD and delaying CKD progression. Furthermore, other therapeutic methods such as treating or avoiding comorbidities and AKI, ensuring appropriate exercise and incremental transition to dialysis treatment may help ameliorate and prevent PEW development in CKD patients. Summary: Using tailored precision nutrition approaches and nutritional supplementation with or without other beneficial strategies may help prevent and treat PEW and its consequent occurrence of CKD progression.

1 July 2025 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
YNYoko Narasaki
Yoko Narasaki
CRConnie Rhee
Connie Rhee
ZLZhaoping Li
Zhaoping Li
Precision nutrition uses an individualized approach in which dietary interventions are tailored according to patients' genetic, biologic, and environmental factors. There are various nutritional guidelines specific to patients with CKD, and while rigorous, they provide generalized recommendations that may not fully address the unique nutritional needs of individual patients. For example, while guidelines endorse prescription of low-protein diets among people with metabolically stable stages 3–5 non–dialysis-dependent CKD to reduce kidney disease progression, these recommendations do not fully account for the genetic, metabolic, or physiologic factors that affect how different patients respond to specific dietary interventions. Furthermore, older patients with CKD may require different levels of protein intake compared with younger individuals, given that aging affects protein metabolism. In contrast to conventional nutritional management approaches, which typically use a one-size-fits-all model, precision nutrition and personalized nutrition use an individualized approach. Although the terms precision nutrition and personalized nutrition are sometimes used interchangeably, there are nuanced differences in their definitions such that precision nutrition is more data-driven and uses precise information ( e.g ., genetic, microbiome, and metabolic) to inform management, whereas personalized nutrition encompasses a broader approach that also takes into consideration factors such as lifestyle, environment, and patients' preferences. Precision nutrition is evolving rapidly with advances in data collection, deep data analysis, and modeling with application of artificial intelligence, while personalized nutrition is what we practice today leveraging available data and guidelines to meet each individual patient's needs. Numerous advancements have led to a growing armamentarium of tools in precision nutrition, including nutrigenetics, nutrigenomics, microbiome profiling, metabolomics, and proteomics, which can be leveraged to guide dietary recommendations according to an individual's unique characteristics. In this review, we examine the role of precision nutrition in CKD, tools used in precision medicine, and practical application of these approaches in treating patients with kidney disease.

25 October 2025 in Toxins
Verified
Journal Article
Open access
PDF file
TBThuy-Anh Bui
Thuy-Anh Bui
AYAmy S. You
Amy S. You
SKSara S. Kalantar
Sara S. Kalantar
JYJi Hoon Yoon
Ji Hoon Yoon
YNYoko Narasaki
Yoko Narasaki
CRConnie Rhee
Connie Rhee
Background: While experimental models show that leptin and adiponectin have inverse effects on the cardiovascular system, it has been suggested that the leptin-to-adiponectin (L/A) ratio may be an important predictor of cardiovascular disease and death. Higher circulating leptin and adiponectin levels are observed in uremia due to decreased renal degradation and/or clearance and increased production. We sought to examine the association between the L/A ratio and mortality in a prospective hemodialysis cohort. Methods: Among a prospective cohort of 448 hemodialysis patients from the NIH “Malnutrition, Diet, and Racial Disparities in Chronic Kidney Disease (CKD) (MADRAD) study who underwent leptin and adiponectin measurements, we examined characteristics associated with high leptin and adiponectin (defined as the highest tertile) using logistic regression. We then examined the association of L/A ratio levels (categorized as tertiles) with all-cause mortality using Cox regression. Results: Multivariable logistic regression analyses showed female sex, diabetes, presence of an arteriovenous fistula/graft, and lower serum albumin, IL-6, and adiponectin were associated with high leptin, whereas female sex, longer vintage, Black race, higher IL-6, and lower leptin were associated with high adiponectin. When examining L/A ratios, the highest tertile was associated with lower mortality in case-mix Cox models (ref: lowest tertile): HR (95% CI) 0.14 (0.06–0.35). These associations were robust in analyses that additionally adjusted for laboratory covariates: (HR 95% CI) 0.18 (0.07–0.46). Conclusions: In a prospective cohort of hemodialysis patients, inflammation and malnutrition markers were associated with lower leptin and higher adiponectin levels. Additionally, high L/A ratio levels were associated with lower mortality. Further studies are needed to determine the mechanisms relating adipocytokines, inflammation and nutrition, and survival in this population.

30 September 2024 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
YNYoko Narasaki
Yoko Narasaki
MSMan Kit Siu
Man Kit Siu
MNMatthew Nguyen
Matthew Nguyen
Kamyar Kalantar-ZadehKamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh
CRConnie Rhee
Connie Rhee
Dialysis has been the dominant treatment regimen in end-stage kidney disease as a means to remove uremic waste products and to maintain electrolyte, acid base, and fluid balance. However, given that dialysis may not always provide a survival benefit nor improved quality of life in certain subpopulations, there is growing recognition of the need for conservative and preservative management as an alternative treatment strategy for advanced chronic kidney disease (CKD). Personalized nutritional management tailored to patient’s sociodemographics, social needs, psychological status, health literacy level, and preferences is a key component of conservative and preservative care, as well as in the management of patients transitioning from non-dialysis dependent CKD to dialysis. In this review, we discuss the nutritional and metabolic alterations that ensue in CKD; the rationale for low-protein diets in the conservative and preservative management of advanced CKD; the role of plant-based diets in kidney health; emerging data on dietary potassium and sodium intake on CKD outcomes; and the practical implementation of dietary interventions in advanced kidney disease.